FREE OVERNIGHT SHIPPING
.png)
In stock: Same day prescriptions and free overnight shipping
Compound Tirzepatide drops are administered via daily doses under the tongue. They are a safe and popular alternative for patients that are uncomfortable with self-injections.
Sublingual medication works by placing the drug under the tongue, where it dissolves and is absorbed directly into the bloodstream through the tissues.
The area under the tongue has a rich supply of blood vessels, which allows the medication to bypass the digestive system and liver, leading to faster and more efficient absorption compared to oral medications that are swallowed.
Semaglutide and tirzepatide are both medications used for weight loss, but they have distinct differences.
Semaglutide is a GLP-1 receptor agonist, which helps to regulate blood sugar by enhancing insulin secretion, slowing gastric emptying, and promoting satiety.
Tirzepatide, on the other hand, is a dual agonist, targeting both the GLP-1 and GIP receptors, offering enhanced glucose control and weight loss by combining the effects of both incretin hormones. Clinical trials suggest that tirzepatide offers superior efficacy in both glucose lowering and weight reduction compared to semaglutide.
Compound Tirzepatide drops are administered via daily doses under the tongue. They are a safe and popular alternative for patients that are uncomfortable with self-injections.
Sublingual medication works by placing the drug under the tongue, where it dissolves and is absorbed directly into the bloodstream through the tissues.
The area under the tongue has a rich supply of blood vessels, which allows the medication to bypass the digestive system and liver, leading to faster and more efficient absorption compared to oral medications that are swallowed.
Tirzepatide is a novel medication that works by targeting two key receptors involved in glucose and energy regulation: the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor.
By activating these receptors, Tirzepatide enhances insulin secretion in response to meals, inhibits glucagon release, and slows gastric emptying, which helps to control blood sugar levels. Additionally, it promotes feelings of fullness and reduces appetite, leading to weight loss.
The dual agonist action of Tirzepatide leverages the complementary effects of GLP-1 and GIP, resulting in improved glycemic control and significant weight reduction in patients.
We believe in a sustainable and flexible approach to nutrition, without imposing limitations on your diet. Our goal is to guide you in establishing healthy eating habits, complemented by the medication's ability to decrease appetite and “food noise”. We encourage maintaining a nourishing, high-protein diet, but most patients are able to lose weight without the need for uncomfortably restrictive dieting or calorie counting.
Common side effects of tirzepatide are usually mild and may include:
• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Decreased appetite
• Indigestion
The majority of side effects are transient and typically resolve spontaneously. Nevertheless, if side effects persist or deteriorate, seek guidance from a healthcare professional.
Willow also offers Odansetron to manage side effects if they occur. This medication is commonly used to prevent nausea and vomiting.
Tirzepatide Patient Safety Information
When stopping Tirzepatide abruptly, some patients may experience mild to moderate weight gain. Others may maintain the weight loss they achieved while on the medication. We recommend patients work with their Willow physician to slowly decrease their dose in order to maintain their weight loss achievements.
You may notice an increase in appetite and a return of food cravings, allowing you to eat more without feeling as full. However, stopping Tirzepatide is a safe and common practice that doesn't involve serious health risks. By gradually tapering off the medication with your physician’s guidance, you can better manage these changes and maintain your health and wellness goals.
Tirzepatide is administered once a week via a subcutaneous injection. Don’t worry! The needle is very small and short, making self-injection quick & easy. We’ll provide you with detailed written and video instructions that make the process simple and easy to follow. We even include a link to a soothing Spotify playlist to play in the background if you wish.
